associated toxicities of novel therapies for cll
Published 9 months ago • 141 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
0:51
novel therapies in the future of cll treatment
-
3:47
novel targeted therapies for cll
-
1:22
protacs: potential novel agents for the treatment of cll
-
1:26
state-of-the-art therapies for cll
-
4:14
novel therapies for the treatment of cll, mcl and fl
-
1:01
cll resistance mechanisms in the era of novel agents
-
1:28
the future of cll treatment
-
23:23
identifying and treating high-risk patients in 2023
-
4:34
arthur's story: his cll diagnosis. challenges, treatments and future hope.
-
4:05
comparing continuous and fixed duration therapy in cll
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:49
the future of cll: managing new toxicities and improved categorization
-
0:53
the future of cll treatment
-
2:36
transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (cll)?
-
1:11
exciting updates in all and the value of novel immunotherapies
-
3:50
relevance of current prognostication and prediction markers for cll with new targeted therapies
-
1:31
novel approaches to cll treatment
-
1:09
cll treatment: novel agents vs. cellular therapies
-
1:39
novel cll therapies: the future
-
2:14
novel approaches to first line cll treatment
-
1:21
outcomes of patients with cll-associated autoimmune cytopenias treated with different therapies